SARGENT INVESTMENT GROUP, LLC – Cytosorbents Corporation Transaction History
SARGENT INVESTMENT GROUP, LLC portfolio value:
$2.02M
portfolio value
SARGENT INVESTMENT GROUP, LLC quarter portfolio value change:
-37.90%
quarter
Cytosorbents Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +13.37% | 130.73K shares | -113K | $1.36 | 1.10M |
| Q2 2022 | share | Increase | +18.14% | 150.11K shares | -498K | $2.19 | 977.49K |
| Q1 2022 | share | Increase | +5.42% | 42.54K shares | -649K | $3.19 | 827.38K |
| Q4 2021 | share | Decrease | -18.60% | -179.30K shares | -4.54M | $4.05 | 784.83K |
| Q3 2021 | share | Increase | +12.59% | 107.82K shares | 1.36M | $8.12 | 964.14K |
| Q2 2021 | share | Increase | +9.20% | 72.14K shares | -342K | $7.55 | 856.31K |
| Q1 2021 | share | Increase | +16.42% | 110.58K shares | 1.43M | $8.68 | 784.17K |
| Q4 2020 | share | Decrease | -2.76% | -19.15K shares | -156K | $7.97 | 673.58K |
| Q3 2020 | share | Decrease | -1.01% | -7.06K shares | -1.45M | $7.98 | 692.73K |
| Q2 2020 | share | Increase | +48.34% | 228.05K shares | 3.32M | $9.9 | 699.80K |
| Q1 2020 | share | Increase | +103.34% | 239.75K shares | 2.75M | $7.73 | 471.75K |
| Q4 2019 | share | Decrease | -21.60% | -63.91K shares | -595K | $3.85 | 232.00K |
| Q3 2019 | share | Decrease | -11.38% | -37.99K shares | -719K | $5.03 | 295.91K |
| Q2 2019 | share | Increase | +15.91% | 45.84K shares | 26K | $6.61 | 333.91K |
| Q1 2019 | share | Increase | +15.49% | 38.64K shares | 166K | $7.57 | 288.07K |
| Q4 2018 | share | Increase | 0.00% | 249.43K shares | 2.01M | $8.08 | 249.43K |